Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Promazine (substance) |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 25mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 100mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 100mg/5mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine (as chlorpromazine hydrochloride) 100 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
chlorhydrate de chlorpromazine 25 mg/mL, ampoule de 2 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 50mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride [nausea] [see dh2..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Product containing precisely chlorpromazine (as chlorpromazine hydrochloride) 25 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine 50 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Product containing chlorpromazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Product containing chlorpromazine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 25mg injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Oral form chlorpromazine m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 75mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Chlorpromazine hydrochloride 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Alimemazine |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Levomepromazine (substance) |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Product containing chlorpromazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Product containing propylamino derivative of phenothiazine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
1 |
Promazine hydrochloride |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Levomepromazine maleate |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Alimemazine tartrate |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|
Levomepromazine hydrochloride |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Some |
|